SHANG.FOS.PHARM.GR.H YC 1
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally. The company offers pharmaceutical products for anti-tumor and immune modulation, metabolism and alimentary system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, le… Read more
Market Cap & Net Worth: SHANG.FOS.PHARM.GR.H YC 1 (08HH)
SHANG.FOS.PHARM.GR.H YC 1 (F:08HH) has a market capitalization of $1.19 Billion (€1.16 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #3537 globally and #327 in its home market, demonstrating a -2.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SHANG.FOS.PHARM.GR.H YC 1's stock price €2.10 by its total outstanding shares 551940500 (551.94 Million).
SHANG.FOS.PHARM.GR.H YC 1 Market Cap History: 2020 to 2026
SHANG.FOS.PHARM.GR.H YC 1's market capitalization history from 2020 to 2026. Data shows growth from $1.03 Billion to $1.19 Billion (327.18% CAGR).
SHANG.FOS.PHARM.GR.H YC 1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SHANG.FOS.PHARM.GR.H YC 1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 08HH by Market Capitalization
Companies near SHANG.FOS.PHARM.GR.H YC 1 in the global market cap rankings as of March 18, 2026.
Key companies related to SHANG.FOS.PHARM.GR.H YC 1 by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
SHANG.FOS.PHARM.GR.H YC 1 Historical Marketcap From 2020 to 2026
Between 2020 and today, SHANG.FOS.PHARM.GR.H YC 1's market cap moved from $1.03 Billion to $ 1.19 Billion, with a yearly change of 327.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.19 Billion | +0.10% |
| 2025 | €1.19 Billion | +22.93% |
| 2024 | €965.97 Million | +11.55% |
| 2023 | €865.97 Million | -24.75% |
| 2022 | €1.15 Billion | +3.58% |
| 2021 | €1.11 Billion | +7.72% |
| 2020 | €1.03 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SHANG.FOS.PHARM.GR.H YC 1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.19 Billion USD |
| MoneyControl | $1.19 Billion USD |
| MarketWatch | $1.19 Billion USD |
| marketcap.company | $1.19 Billion USD |
| Reuters | $1.19 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.